By allowing cancer centers to extend their Cancer Center Support Grant award period from five to seven years, NCI hopes to enable eligible centers to spend less time preparing for a grant renewal in favor of conducting more research and setting long-term goals.
More than a year after a catastrophic shortage of platinum-based chemotherapy drugs swept through the U.S., FDA on June 28 officially removed carboplatin and cisplatin from the drug shortage list.
